Steven Cohen’s Legend Biotech LEGN Stock Holding History

Steven Cohen’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$88.8M	Sell	3,076,124 -809,893	-21%	-$21.8M	0.1%	237
2026 Q1	$70.3M	Buy	3,886,017 +1,101,211	+40%	+$21M	0.09%	257
2025 Q4	$60.5M	Buy	+2,784,806	New	+$79.8M	0.07%	332
2025 Q3	–	Sell	-227,906	Closed	-$8.09M	–	2517
2025 Q2	$8.09M	Buy	+227,906	New	+$7.39M	0.02%	817
2024 Q4	–	Sell	-195,371	Closed	-$9.52M	–	2273
2024 Q3	$9.52M	Sell	195,371 -109,149	-36%	-$5.81M	0.02%	662
2024 Q2	$13.5M	Buy	+304,520	New	+$14M	0.04%	512
2022 Q4	–	Sell	-107,000	Closed	-$4.37M	–	1671
2022 Q3	$4.37M	Sell	107,000 -105,900	-50%	-$4.97M	0.02%	760
2022 Q2	$11.7M	Buy	+212,900	New	+$8.99M	0.05%	473
2021 Q2	–	Sell	-1,639,200	Closed	-$47.6M	–	1078
2021 Q1	$47.6M	Buy	+1,639,200	New	+$44.7M	0.22%	116

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Steven Cohen's LEGN Position: Q2 2026 in Review

Steven Cohen reduced its Legend Biotech (LEGN) stake by 21% in Q2 2026, selling an estimated $21.8M and leaving 3,076,124 shares worth $88.8M. The position accounts for 0.1% of the portfolio, ranked #237.

Steven Cohen first reported a position in LEGN in Q1 2021 and has held it in 9 quarters since. 217 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

Steven Cohen held 3,076,124 shares of Legend Biotech worth $88.8M as of Q2 2026.
Steven Cohen sold 809,893 Legend Biotech shares in Q2 2026, an estimated $21.8M.
Legend Biotech made up 0.1% of Steven Cohen's portfolio in Q2 2026, its #237 holding.
Steven Cohen first reported a position in Legend Biotech in Q1 2021 and has held it in 9 quarters since.
217 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.